Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Data Review and Approval Workflow

Posted on By

Standard Operating Procedure for Data Review and Approval Workflow

Purpose

The purpose of this SOP is to establish procedures for the systematic review and approval of electronic data within the pharmaceutical manufacturing facility. This ensures data accuracy, integrity, and compliance with regulatory requirements.

Scope

This SOP applies to all personnel involved in the generation, processing, and approval of electronic data, including operators, quality control personnel, and quality assurance personnel.

Responsibilities

  • Data Owners: Responsible for ensuring the accuracy and completeness of data within their respective areas and initiating the data approval process.
  • Quality Control Personnel: Responsible for conducting routine data reviews, documenting observations, and recommending corrective actions when necessary.
  • Quality Assurance Personnel: Responsible for the final approval of electronic data, ensuring compliance with regulatory standards and providing oversight of the data review process.
See also  SOP for Data Integrity in Computerized Systems Validation

Procedure

  1. Identification of Data for Review: Collaborate with data owners to identify electronic data that requires review and approval. Categorize data based on its impact on product quality and regulatory compliance.
  2. Data Review Plan: Develop a data review plan outlining the objectives, scope, timelines, resources, and responsibilities for the review process. Include risk assessments and mitigation strategies.
  3. Initiation of Data Review: Data owners initiate the data review process by submitting the relevant data for review to the designated quality control personnel.
  4. Data
Review by Quality Control: Quality control personnel conduct a thorough review of the submitted data, ensuring accuracy, completeness, and compliance with established procedures. Document observations and recommendations for corrective actions if needed.
  • Correction of Identified Issues: If issues are identified during the review process, data owners are responsible for implementing corrective actions promptly. Document the corrective actions taken.
  • Final Approval by Quality Assurance: Quality assurance personnel conduct a final review of the data, including the findings and corrective actions from quality control. Approve the data for further use or request additional actions if necessary.
  • Documentation of Review and Approval: Maintain detailed records of all data review and approval activities, including the review plan, review logs, corrective action records, and final approval records.
  • Communication: Communicate the completion of data review and approval to relevant stakeholders. Provide information on the status of the data and any actions taken to address identified issues.
  • Periodic Review of the Workflow: Conduct periodic reviews of the data review and approval workflow to assess its effectiveness. Address any identified issues and update the procedures accordingly.
  • Training: Provide training to personnel involved in data review and approval activities to ensure a thorough understanding of the procedures and the importance of data integrity.
  • Abbreviations

    No abbreviations are used in this SOP.

    Documents

    • Data Review Plan
    • Data Review Logs
    • Corrective Action Records
    • Final Approval Records

    Reference

    ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

    SOP Version

    Version 1.0

    See also  SOP for Data Anonymization and Pseudonymization
    Data Integrity Tags:Data accuracy, Data assurance, Data audit, Data confidentiality, Data consistency, Data encryption, Data governance, Data protection, Data quality, Data reliability, Data security, Data transparency, Data validation, Data verification, Database integrity, Information assurance, Information integrity, Trustworthy data

    Post navigation

    Previous Post: SOP for Metal Detection Process
    Next Post: SOP for Batch Record Keeping

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version